Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours

AA Kattentidt-Mouravieva, IRR Geurts-Giele, Ronald de Krijger, MM Noesel, CP Ven, Ans van den Ouweland, Joan Kromosoeto, Winand Dinjens, Erik jan Dubbink, Ron Smits, Anja Wagner

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)


Objective: Desmoid tumours are rare mesenchymal tumours with unpredictable progression and high recurrence risk. They can occur sporadically or in association with Familial Adenomatous Polyposis (FAP), which is caused by germline APC mutations. The Wnt/beta-catenin pathway has a central role in the pathogenesis of desmoid tumours. These tumours can occur due to either a somatic CTNNB1 or APC mutation but can also be the first manifestation of FAP. Because germline APC analysis is not routinely performed in children with desmoid tumours, the diagnosis FAP may escape detection. The aim of this study is to form guidelines for the identification of possible APC germline mutation carriers among children with desmoid tumours, based on CTNNB1 mutation analysis and immunohistochemical analysis (IHC) for beta-catenin. Patients and methods: We performed IHC of beta-catenin and mutation analysis of CTNNB1 and APC in 18 paediatric desmoid tumours, diagnosed between 1990 and 2009 in the Erasmus MC, Rotterdam. Results: In 11 tumours, IHC showed an abnormal nuclear beta-catenin accumulation. In this group a CTNNB1 mutation was detected in seven tumours. In two tumours with an abnormal nuclear beta-catenin accumulation and no CTNNB1 mutation, an APC mutation was identified, which appeared to be a germline mutation. Conclusions: Aberrant staining of beta-catenin in paediatric desmoids helps to identify children at risk for FAP. We recommend to screen paediatric desmoid tumours for nuclear localisation of beta-catenin and consequently for CTNNB1 mutations. For patients with nuclear beta-catenin expression and no CTNNB1 mutations, APC mutation analysis should be offered after genetic counselling. (C) 2012 Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)1867-1874
Number of pages8
JournalEuropean Journal of Cancer
Issue number12
Publication statusPublished - 2012

Research programs

  • EMC MGC-02-96-01
  • EMC MM-02-54-03
  • EMC MM-03-24-01
  • EMC MM-04-20-01

Cite this